Risk management strategies of synthetic cannabis users.
作者信息
Campos Stephanie, Benoit Ellen, Dunlap Eloise
机构信息
National Development & Research Institutes, Inc.
出版信息
Drugs Alcohol Today. 2019 Oct 23;19(4):270-281. doi: 10.1108/dat-04-2019-0012. Epub 2019 Sep 2.
Abstract
摘要
相似文献
1
Risk management strategies of synthetic cannabis users.合成大麻使用者的风险管理策略。
Drugs Alcohol Today. 2019 Oct 23;19(4):270-281. doi: 10.1108/dat-04-2019-0012. Epub 2019 Sep 2.
2
Synthetic cannabinoids: the dangers of spicing it up.合成大麻素：增添刺激的危害。
J Psychosoc Nurs Ment Health Serv. 2015 May;53(5):36-43. doi: 10.3928/02793695-20150422-01.
3
[Spice drugs: cannabinoids as a new designer drugs].[香料药物：大麻素作为新型合成毒品]
Adicciones. 2009;21(3):181-6.
4
Spice/K2 drugs--more than innocent substitutes for marijuana.香料/ K2 毒品——不仅仅是大麻的无辜替代品。
Int J Neuropsychopharmacol. 2014 Mar;17(3):509-25. doi: 10.1017/S1461145713001247. Epub 2013 Oct 29.
5
The Synthetic Cannabinoids Phenomenon.合成大麻素现象
Curr Pharm Des. 2016;22(42):6420-6425. doi: 10.2174/1381612822666160919093450.
6
Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.为药理学增添趣味：从结构到不良事件的合成大麻素综述
Adv Pharmacol. 2017;80:135-168. doi: 10.1016/bs.apha.2017.05.001. Epub 2017 Jun 20.
7
The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.合成大麻素现象：从结构到毒理学特性。综述。
Crit Rev Toxicol. 2020 May;50(5):359-382. doi: 10.1080/10408444.2020.1762539. Epub 2020 Jun 12.
8
Spice drugs as a new trend: mode of action, identification and legislation.香料毒品作为一种新趋势：作用模式、鉴定和立法。
Toxicol Lett. 2010 Sep 1;197(3):157-62. doi: 10.1016/j.toxlet.2010.06.002. Epub 2010 Jun 8.
9
Psychosis and synthetic cannabinoids.精神病与合成大麻素。
Psychiatry Res. 2018 Oct;268:400-412. doi: 10.1016/j.psychres.2018.08.012. Epub 2018 Aug 10.
10
New and Emerging Illicit Psychoactive Substances.新型及新兴非法精神活性物质。
Med Clin North Am. 2018 Jul;102(4):697-714. doi: 10.1016/j.mcna.2018.02.010.
本文引用的文献
1
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.合成与非合成大麻素类药物及其不良反应——基于公共卫生视角的综述
Front Public Health. 2018 Jun 7;6:162. doi: 10.3389/fpubh.2018.00162. eCollection 2018.
2
'Nice people doing shady things': Drugs and the morality of exchange in the darknet cryptomarkets.“好人做卑鄙事”：暗网加密货币市场中的毒品与交换道德。
Int J Drug Policy. 2018 Aug;58:78-84. doi: 10.1016/j.drugpo.2018.05.008. Epub 2018 Jun 2.
3
The long tail of a demon drug: The 'bath salts' risk environment.恶魔药物的长尾：“浴盐”风险环境。
Int J Drug Policy. 2018 Jan;51:111-116. doi: 10.1016/j.drugpo.2017.10.007. Epub 2017 Dec 15.
4
Synthetic Cannabinoid Use Among High School Seniors.高中高年级学生中合成大麻素的使用情况。
Pediatrics. 2017 Oct;140(4). doi: 10.1542/peds.2017-1330. Epub 2017 Sep 11.
5
Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.合成大麻素相关危害的增加：基于网络的纵向内容分析结果
Int J Drug Policy. 2017 Jun;44:121-129. doi: 10.1016/j.drugpo.2017.05.007. Epub 2017 Jun 1.
6
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana.合成大麻素与大麻的健康风险行为
Pediatrics. 2017 Apr;139(4). doi: 10.1542/peds.2016-2675. Epub 2017 Mar 13.
7
Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.通过解释现象学分析评估使用合成大麻素的体验。
Harm Reduct J. 2017 Feb 10;14(1):9. doi: 10.1186/s12954-017-0138-1.
8
New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs.新药，新方向？新型精神活性物质和人类增强药物的研究重点
Int J Drug Policy. 2017 Feb;40:1-5. doi: 10.1016/j.drugpo.2017.01.016.
9
New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.暗网市场上的新型精神活性物质（NPS）：对NPS买家和卖家之间论坛活动特征的探索性研究。
Int J Drug Policy. 2017 Feb;40:102-110. doi: 10.1016/j.drugpo.2016.11.007. Epub 2016 Dec 24.
10
Harm Reduction From Below: On Sharing and Caring in Drug Use.自下而上的减少伤害：论吸毒中的分享与关怀。
Contemp Drug Probl. 2016 Sep;43(3):199-215. doi: 10.1177/0091450916663248. Epub 2016 Jul 29.
Zotero 插件